| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/22/2014 | CN101875608B Carveol ester derivative and percutaneous absorption preparation containing same |
| 01/22/2014 | CN101874853B Pills for treating ulcerative colitis and preparation process thereof |
| 01/22/2014 | CN101874817B Brucea javanica oil enteric-coated microcapsule and preparation method |
| 01/21/2014 | US8633325 Method for making insect repellent composition |
| 01/21/2014 | US8633191 Anti-microbial and anti-fungal shampoo for mammals especially humans and dogs |
| 01/21/2014 | US8633178 Natural combination hormone replacement formulations and therapies |
| 01/21/2014 | US8633162 Methods of providing therapeutic effects using cyclosporin components |
| 01/21/2014 | US8633159 Apparatus and method for transdermal delivery of parathyroid hormone agents |
| 01/21/2014 | US8632844 Method for the manufacture of nerve regeneration-inducing tube |
| 01/21/2014 | US8632820 Compositions for achieving a therapeutic effect in an anatomical structure |
| 01/21/2014 | US8632819 Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients |
| 01/21/2014 | US8632818 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients |
| 01/21/2014 | US8632817 Process for dispersing amino acids |
| 01/21/2014 | US8632815 Process for nanoemulsification of curcumin and derivatives of curcumin |
| 01/21/2014 | US8632814 Substrates comprising switchable ferromagnetic nanoparticles |
| 01/21/2014 | US8632813 Prostaglandin compositions and methods for the treatment of vasospasm |
| 01/21/2014 | US8632812 Methods of increasing productivity in older sows while decreasing feed intake |
| 01/21/2014 | US8632811 Silica-based antibacterial and antifungal nanoformulation |
| 01/21/2014 | US8632809 Water insoluble polymer matrix for drug delivery |
| 01/21/2014 | US8632808 Taste-masking solid preparation of pioglitazone |
| 01/21/2014 | US8632807 Pharmaceutical composition |
| 01/21/2014 | US8632805 Controlled-release formulations, method of manufacture, and use thereof |
| 01/21/2014 | US8632804 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
| 01/21/2014 | US8632803 System for delivery of protein in insoluble fibrillar or aggregate form |
| 01/21/2014 | US8632802 Device for transdermal administration of drugs including acrylic polymers |
| 01/21/2014 | US8632801 Stable therapeutic formulations |
| 01/21/2014 | US8632800 Multilayer drug delivery system with barrier against reservoir material flow |
| 01/21/2014 | US8632799 Saline nose wipe and methods of manufacture and use |
| 01/21/2014 | US8632798 Cereal β glucan compositions, methods of preparation and uses thereof |
| 01/21/2014 | US8632797 Targeted delivery of therapeutic agents with lyophilized matrices |
| 01/21/2014 | US8632796 Calcium phosphate/sulfate-based bone implant composition |
| 01/21/2014 | US8632793 Top-biased beneficial components on substrates |
| 01/21/2014 | US8632789 System and method for delivery of DNA-binding chemotherapy drugs using nanoparticles |
| 01/21/2014 | US8632788 Parenteral formulation for epothilone analogs |
| 01/21/2014 | US8632763 Use of a copolymer in the form of a solubiliser for a poorly water-soluble compound |
| 01/21/2014 | US8632755 Consumer noticeable improvement in wetness protection |
| 01/21/2014 | US8632751 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 01/21/2014 | US8632524 Injectable biocompatible material delivery system |
| 01/21/2014 | CA2745782C Pharmaceutical compositions and uses for peptide treatment |
| 01/21/2014 | CA2745034C Ceramic honeycomb structure skin coating |
| 01/21/2014 | CA2739604C Targeted liposome gene delivery |
| 01/21/2014 | CA2671000C Method for suppressing coloring of adhesive preparation containing donepezil and method for reducing amounts of donepezil-related substances formed |
| 01/21/2014 | CA2639921C Microspheres comprising nanocapsules containing a lipophilic drug |
| 01/21/2014 | CA2631123C Composition in the form of a spray containing a corticoid and an oil phase |
| 01/21/2014 | CA2611224C Method for handling adhesive laminate sections |
| 01/21/2014 | CA2568504C Local vascular delivery of p13 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury |
| 01/21/2014 | CA2486473C Vaginal care composition |
| 01/21/2014 | CA2388477C Recombinant gelatins with uniform molecular weight |
| 01/21/2014 | CA2359317C Method of treating restenosis by antisense targeting of c-myc |
| 01/16/2014 | WO2014012117A1 Compositions and methods for localized drug delivery through mammary papillae |
| 01/16/2014 | WO2014012105A1 Encapsulation of immiscible phases in silk fibroin biomaterials |
| 01/16/2014 | WO2014012099A1 Encapsulation of fragrance and/or flavors in silk fibroin biomaterials |
| 01/16/2014 | WO2014012063A1 Pharmaceutical dosage forms comprising ecopipam free base or pharmaceutically acceptable salts thereof |
| 01/16/2014 | WO2014011908A1 Apolipoprotein mixtures |
| 01/16/2014 | WO2014011875A1 Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof |
| 01/16/2014 | WO2014011830A1 Extended release, abuse deterrent pharmaceutical compositions |
| 01/16/2014 | WO2014011672A1 Etanercept formulations exhibiting marked reduction in sub-visible particles |
| 01/16/2014 | WO2014011629A1 Stable aqueous formulations of etanercept |
| 01/16/2014 | WO2014011040A1 Method for producing a protein and lipid comprising composition with reduced digestive coagulation |
| 01/16/2014 | WO2014011039A1 Method for producing a protein comprising composition with reduced digestive coagulation |
| 01/16/2014 | WO2014011030A1 Method for producing a protein comprising composition with reduced digestive coagulation |
| 01/16/2014 | WO2014011029A1 Method for producing a protein and lipid comprising composition with reduced digestive coagulation |
| 01/16/2014 | WO2014010924A1 Pharmaceutical composition for topical administration comprising vancomycin or its salt and dexamethasone phosphate or its salt |
| 01/16/2014 | WO2014010586A1 Pharmaceutical preparation for injection |
| 01/16/2014 | WO2014010577A1 Aqueous pectin solution |
| 01/16/2014 | WO2014010528A1 Oxaliplatin-containing pharmaceutical composition |
| 01/16/2014 | WO2014010100A1 Cosmetic composition comprising composite sunscreen particles |
| 01/16/2014 | WO2014010008A1 Capsule-filling composition of candesartan cilexetil |
| 01/16/2014 | WO2014009930A1 Use of nanodiamonds for generating free radicals for therapeutic purposes under radiation |
| 01/16/2014 | WO2014009817A1 Pharmaceutical composition of febuxostat |
| 01/16/2014 | WO2014009806A1 Solid composition comprising iron for use in iron deficient conditions |
| 01/16/2014 | WO2014009805A1 Liquid compositions comprising iron for use in the treatment of disorders or diseases related to an iron deficiency |
| 01/16/2014 | WO2014009793A1 Diclofenac solution for external use |
| 01/16/2014 | WO2014009500A1 Anti-tumoral composition comprising the compound 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea |
| 01/16/2014 | WO2014009437A1 Oxidation stability of abiraterone acetate |
| 01/16/2014 | WO2014009436A1 Nanosuspension of abiraterone acetate |
| 01/16/2014 | WO2014009434A1 Self-microemulsifying drug delivery system of abiraterone or abiraterone acetate |
| 01/16/2014 | WO2014009328A1 A method to produce a medicinal product comprising a biologically active protein and the resulting product |
| 01/16/2014 | WO2014009241A1 Diclofenac formulations |
| 01/16/2014 | WO2014008648A1 A composition comprising reduced glutathione and acetaminophen and preparation method thereof |
| 01/16/2014 | WO2014008602A1 Solid maple syrup compositions |
| 01/16/2014 | WO2014008594A1 System and method for using ultrasound-stimulated microbubble exposures to induce ceramide accumulation in endothelial and tumor cells |
| 01/16/2014 | WO2013180459A3 Catechol graft copolymer, copolymer composition containing crosslinked copolymer, functional adhesive matrix composition, and method for preparing same |
| 01/16/2014 | WO2013177067A3 Herbal composition for treatment of gastrointestinal inflammatory diseases and method to prepare and use thereof |
| 01/16/2014 | US20140018751 Transdermal therapeutic system with crystallization-inhibiting protective film (Release liner) |
| 01/16/2014 | US20140018750 Method and device or pharmaceutical compositions for the transdermal delivery of magnesium directly to the neuromuscular junction for the treatment of muscle cramping |
| 01/16/2014 | US20140018438 Method of destroying bacterial biofilm using sterile intravenous or intracavernous glycerin |
| 01/16/2014 | US20140018402 Pharmaceutical composition for preventing or treating macular degeneration |
| 01/16/2014 | US20140018397 Sustained Release Aminopyridine Composition |
| 01/16/2014 | US20140018395 Controlled Release Auris Sensory Cell Modulator Compositions and Methods for the Treatment of Otic Disorders |
| 01/16/2014 | US20140018369 Controlled release sterile injectable aripiprazole formulation and method |
| 01/16/2014 | US20140018346 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer |
| 01/16/2014 | US20140018323 Sustained-release injectable formulation |
| 01/16/2014 | US20140018316 Ophthalmic pharmaceutical composition |
| 01/16/2014 | US20140018298 Citrate free pharmaceutical compositions comprising anakinra |
| 01/16/2014 | US20140018295 Nasal delivery |
| 01/16/2014 | US20140017402 Paper tissue with high lotion transferability |
| 01/16/2014 | US20140017390 Tableting Aid |
| 01/16/2014 | US20140017348 Hemostatic Preparation Containing an Extract of Golden Moss |
| 01/16/2014 | US20140017346 Gelatin-free, isomaltulose-containing soft caramel |